From: An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs
No
Sample
Entry inhibition (%)
Post-entry inhibition (%)
Entry and post-entry inhibition (%)
1
FR3T3 (10 μg/mL)
33.86 ± 2.19
64.04 ± 3.06
83.07 ± 4.00
2
FR3T3 (20 μg/mL)
61.68 ± 0.10
83.86 ± 2.58
93.44 ± 5.29